ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026
Recent Advances in Metabolic and Bariatric Surgery: A Narrative Review of Therapeutic Strategies for Weight Loss and Metabolic Health.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic and bariatric surgery (MBS) plays an important role in the management of obesity and related metabolic disorders, particularly in patients who meet established surgical criteria. The field has transitioned from open procedures to laparoscopic surgery, and the current landscape includes multiple operations with distinct efficacy-risk profiles. Alongside established procedures such as sleeve gastrectomy (SG), newer approaches-such as endoscopic metabolic interventions and robot-assisted platforms-are being evaluated for their feasibility, safety, learning curve, and potential outcome benefits. However, important questions remain regarding long-term durability, complication patterns, revisional surgery, patient selection, cost-effectiveness. To map these developments, we screened PubMed literature up to March 10, 2026 using terms such as "metabolic and bariatric surgery" and "sleeve gastrectomy", with emphasis on the International Federation for Surgery and Other Therapies for Obesity (IFSO) and higher-level evidence when available. We then synthesize findings across surgical technique evolution, indications and complications, unresolved challenges, and future directions, including how artificial intelligence (AI) and machine learning (ML) may support perioperative risk prediction and individualized treatment planning. This work aims to support clinicians in tailoring MBS plans and to guide future research priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.